Reprogramming Cancer: A New Era of AI-Powered Immunotherapy with CancerVax’s Adam Grant

In this episode, Ayesha spoke with Adam Grant, PhD, Principal Scientist at CancerVax, to discuss the company’s Universal Cancer Treatment Platform.

The immunotherapy tool uses AI to train the immune system to recognize and eliminate cancer cells by modifying those cells to resemble known pathogens like measles. This innovative approach prompts a stronger and more effective immune response compared to traditional immunotherapies.

Dr. Grant, a leading computational biologist and one of the inventors behind the platform, shares insights into how AI and next-generation sequencing are revolutionizing fields like cancer immunotherapy.

Dr. Grant previously served as a Bioinformatician at Xenter Medical Technologies and as a Computational Scientist at RAPT Therapeutics. His innovations include software designed to improve cancer antigen detection and a gene-signature approach for selecting treatments for breast cancer.

Dr. Grant earned a Bachelor of Science (BSc) in Bioinformatics from Brigham Young University and a PhD in Cancer Biology with an emphasis in Bioinformatics from the University of Arizona.

From discovering new drug targets to engineering smarter immune strategies, tune in to hear Dr. Grant discuss how bioinformatics is reshaping innovations in cancer immunotherapy.

For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media

Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured